364 related articles for article (PubMed ID: 24632771)
1. [Some practical questions on chronic stipsis treatment with prucalopride].
Bellacosa L; Cogliandro R; Cremon C; De Giorgio R; Barbara G; Stanghellini V
Minerva Gastroenterol Dietol; 2014 Mar; 60(1):85-99. PubMed ID: 24632771
[TBL] [Abstract][Full Text] [Related]
2. Clinical trial: the efficacy of open-label prucalopride treatment in patients with chronic constipation - follow-up of patients from the pivotal studies.
Camilleri M; Van Outryve MJ; Beyens G; Kerstens R; Robinson P; Vandeplassche L
Aliment Pharmacol Ther; 2010 Nov; 32(9):1113-23. PubMed ID: 21039673
[TBL] [Abstract][Full Text] [Related]
3. Prucalopride succinate for the treatment of constipation: an update.
Bassotti G; Gambaccini D; Bellini M
Expert Rev Gastroenterol Hepatol; 2016; 10(3):291-300. PubMed ID: 26647167
[TBL] [Abstract][Full Text] [Related]
4. Oral prucalopride in children with functional constipation.
Winter HS; Di Lorenzo C; Benninga MA; Gilger MA; Kearns GL; Hyman PE; Vandeplassche L; Ausma J; Hoppenbrouwers M
J Pediatr Gastroenterol Nutr; 2013 Aug; 57(2):197-203. PubMed ID: 23535761
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of severe chronic constipation: differential roles of conventional laxatives and the prucalopride prokinetic].
Layer P; Dathe K; Dignass A; Faiss S; Galle P; Lerch MM; Malfertheiner P; Wehrmann T; Zeuzem S
Z Gastroenterol; 2011 Aug; 49(8):969-70. PubMed ID: 21796580
[No Abstract] [Full Text] [Related]
6. Neurological and psychiatric adverse events with prucalopride: case report and possible mechanisms.
Carnovale C; Pellegrino P; Perrone V; Antoniazzi S; Pozzi M; Nisic A; Clementi E; Radice S
J Clin Pharm Ther; 2013 Dec; 38(6):524-5. PubMed ID: 23889005
[TBL] [Abstract][Full Text] [Related]
7. Prucalopride. In chronic constipation: poorly documented risks.
Prescrire Int; 2011 May; 20(116):117-20. PubMed ID: 21648173
[TBL] [Abstract][Full Text] [Related]
8. Use of prucalopride in adults with chronic idiopathic constipation.
Vijayvargiya P; Camilleri M
Expert Rev Clin Pharmacol; 2019 Jul; 12(7):579-589. PubMed ID: 31096799
[No Abstract] [Full Text] [Related]
9. Prucalopride: A Review in Chronic Idiopathic Constipation.
Garnock-Jones KP
Drugs; 2016 Jan; 76(1):99-110. PubMed ID: 26628294
[TBL] [Abstract][Full Text] [Related]
10. Effect of prucalopride on symptoms of chronic constipation.
Tack J; Stanghellini V; Dubois D; Joseph A; Vandeplassche L; Kerstens R
Neurogastroenterol Motil; 2014 Jan; 26(1):21-7. PubMed ID: 24106924
[TBL] [Abstract][Full Text] [Related]
11. Prucalopride for the treatment of constipation: a view from 2015 and beyond.
Bassotti G; Usai Satta P; Bellini M
Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):257-262. PubMed ID: 30791758
[TBL] [Abstract][Full Text] [Related]
12. Randomised clinical trial: macrogol/PEG 3350+electrolytes versus prucalopride in the treatment of chronic constipation -- a comparison in a controlled environment.
Cinca R; Chera D; Gruss HJ; Halphen M
Aliment Pharmacol Ther; 2013 May; 37(9):876-86. PubMed ID: 23480216
[TBL] [Abstract][Full Text] [Related]
13. Prucalopride for the treatment of women with chronic constipation in whom standard laxative regimens have failed to provide adequate relief.
Pennant M; Orlando R; Barton P; Bayliss S; Routh K; Meads C
Health Technol Assess; 2011 May; 15 Suppl 1():43-50. PubMed ID: 21609652
[TBL] [Abstract][Full Text] [Related]
14. Prucalopride: evaluation of the pharmacokinetics, pharmacodynamics, efficacy and safety in the treatment of chronic constipation.
Tack J; Corsetti M
Expert Opin Drug Metab Toxicol; 2012 Oct; 8(10):1327-35. PubMed ID: 22985444
[TBL] [Abstract][Full Text] [Related]
15. Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives.
Tack J; van Outryve M; Beyens G; Kerstens R; Vandeplassche L
Gut; 2009 Mar; 58(3):357-65. PubMed ID: 18987031
[TBL] [Abstract][Full Text] [Related]
16. A placebo-controlled trial of prucalopride for severe chronic constipation.
Camilleri M; Kerstens R; Rykx A; Vandeplassche L
N Engl J Med; 2008 May; 358(22):2344-54. PubMed ID: 18509121
[TBL] [Abstract][Full Text] [Related]
17. Prucalopride: a review of its use in the management of chronic constipation.
Keating GM
Drugs; 2013 Nov; 73(17):1935-50. PubMed ID: 24194435
[TBL] [Abstract][Full Text] [Related]
18. Prucalopride.
Frampton JE
Drugs; 2009; 69(17):2463-76. PubMed ID: 19911858
[TBL] [Abstract][Full Text] [Related]
19. What role for prucalopride in constipation?
Drug Ther Bull; 2011 Aug; 49(8):93-6. PubMed ID: 21831905
[TBL] [Abstract][Full Text] [Related]
20. Systematic review with meta-analysis: highly selective 5-HT4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation.
Shin A; Camilleri M; Kolar G; Erwin P; West CP; Murad MH
Aliment Pharmacol Ther; 2014 Feb; 39(3):239-53. PubMed ID: 24308797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
